Viewing Study NCT00165542



Ignite Creation Date: 2024-05-05 @ 11:54 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00165542
Status: COMPLETED
Last Update Posted: 2016-11-23
First Post: 2005-09-12

Brief Title: A-protein Levels in Adult and Pediatric Brain Tumor Patients
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Study Overview

Official Title: Determination of A-Protein Levels in Adult and Pediatric Brain Tumor Patients
Status: COMPLETED
Status Verified Date: 2016-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the sensitivity and specificity of A-PROTEIN levels in patients with brain tumors A-PROTEIN levels will be analyzed both pre and post treatment Levels in blood andor cerebrospinal fluid CSF will be analyzed and correlated with the underlying diagnosis and outcome
Detailed Description: Patients will be identified at the time of presentation to their neurologist neurosurgeon or oncologist
Blood or cerebrospinal fluid will be collected for this study only when they are being collected for other reasons before and after each surgery Samples will also be collected after any event such as significant change in symptoms or radiographic progression
Once the patients condition has been stabilized samples will be take at regular intervals of 1 month The duration of this study is 24 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None